At FAMAR, we are pleased to announce that our new R&D Pilot Plant in Madrid, Spain has been inspected and authorized by Agencia Española de Medicamentos y Productos Sanitarios for solid pharmaceuticals forms.
With a constructed area of more than 1,000 sqm the new Plant is equipped to house state-of-the-art technology to develop and scale-up projects from bench lab of early phases to clinical trial manufacturing.
Our suites are designed to work under FDA standard GMP conditions while ensuring full conditions to handle Safebridge 3A HPAPIs guaranteeing the safety of the personnel and the quality of the product.
Famar is clearly the right partner to deliver your High Potency Drug Development.